Literature DB >> 20099128

Tracking dendritic cells in vivo.

Catherine M Rush1, James M Brewer.   

Abstract

The reasons why certain vaccine adjuvants and/or delivery systems are more or less effective at inducing immune responses or promoting the preferential induction of particular types of response are unknown. While vaccine antigen discovery has benefited from a systematic approach, our limited understanding of the interactions of adjuvants with cells of the immune system has hampered rational adjuvant discovery and handicapped the development of new and more effective vaccines. It is well accepted that the component parts of the immune system do not work in isolation and their interactions occur in distinct and specialised micro- and macro-anatomical locations. Consequently, significant obstacles to the systematic investigation of adjuvant effects have been the complexity of the physiological environments that adjuvants interact with and the difficulty in directly investigating these interactions dynamically in vivo. Here we describe some of the immunological and microscopical techniques that have enabled the analysis of the immune cells and their interactions, in vivo, in real time. It is only by performing such detailed and fundamental studies in vivo that we can fully understand the cellular and molecular interactions that control the immune response. These types of systematic analyses of the events involved in adjuvant action are a prerequisite if we are truly to design, build and target vaccines effectively.

Mesh:

Year:  2010        PMID: 20099128     DOI: 10.1007/978-1-60761-585-9_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro.

Authors:  Tirth R Ghimire; Robert A Benson; Paul Garside; James M Brewer
Journal:  Immunol Lett       Date:  2012-06-23       Impact factor: 3.685

2.  Antigen depot is not required for alum adjuvanticity.

Authors:  Sharon Hutchison; Robert A Benson; Vivienne B Gibson; Abigail H Pollock; Paul Garside; James M Brewer
Journal:  FASEB J       Date:  2011-11-21       Impact factor: 5.191

3.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

4.  Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo.

Authors:  Robert A Benson; Megan K L MacLeod; Benjamin G Hale; Agapitos Patakas; Paul Garside; James M Brewer
Journal:  Elife       Date:  2015-08-10       Impact factor: 8.140

5.  Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation.

Authors:  Fabrizia Bonacina; David Coe; Guosu Wang; Maria P Longhi; Andrea Baragetti; Annalisa Moregola; Katia Garlaschelli; Patrizia Uboldi; Fabio Pellegatta; Liliana Grigore; Lorenzo Da Dalt; Andrea Annoni; Silvia Gregori; Qingzhong Xiao; Donatella Caruso; Nico Mitro; Alberico L Catapano; Federica M Marelli-Berg; Giuseppe D Norata
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

6.  Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination.

Authors:  Marisa Stebegg; Alexandre Bignon; Danika Lea Hill; Alyssa Silva-Cayetano; Christel Krueger; Ine Vanderleyden; Silvia Innocentin; Louis Boon; Jiong Wang; Martin S Zand; James Dooley; Jonathan Clark; Adrian Liston; Edward Carr; Michelle A Linterman
Journal:  Elife       Date:  2020-03-24       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.